Literature DB >> 16930739

Transient supplementation of superoxide dismutase protects endothelial cells against Plasmodium falciparum-induced oxidative stress.

Zacharie Taoufiq1, Paco Pino, Nathalie Dugas, Marc Conti, Maurel Tefit, Dominique Mazier, Ioannis Vouldoukis.   

Abstract

The pathogenesis of cerebral malaria, a major complication of Plasmodium falciparum infection, relies on mechanisms such as cytokine production and cytoadherence of parasitized red blood cells (PRBCs) on microvascular endothelial cells. In this way parasites avoid spleen clearance by sequestration in post-capillary venules of various organs including the brain. Infected erythrocytes adhesion has also been shown to have molecular signaling consequences providing insight on how tissue homeostasis could be comprised by endothelium perturbation. Our previous work demonstrated that PRBCs adhesion to human lung endothelial cells (HLEC) induces caspases activation, oxidative stress and apoptosis. Cytoplasmic Cu/Zn superoxide dismutase (SOD1), which provides the first line of defense against oxidative stress within a cell, is now used as a treatment of numerous diseases including traumatic brain injury and ischemic stroke. In this report, we demonstrated that transient supplementation of SOD1 protects endothelial cells against P. falciparum induced oxidative stress and apoptosis. We also showed a significant decrease in PRBCs cytoadherence through a downregulation of ICAM-1 and an induction of iNOS. Protection of endothelium via antioxidant delivery may constitute a relevant strategy in cerebral malaria treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930739     DOI: 10.1016/j.molbiopara.2006.07.008

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  15 in total

1.  Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes.

Authors:  I M B Francischetti; K B Seydel; R Q Monteiro; R O Whitten; C R Erexson; A L L Noronha; G R Ostera; S B Kamiza; M E Molyneux; J M Ward; T E Taylor
Journal:  J Thromb Haemost       Date:  2006-09-26       Impact factor: 5.824

2.  Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity.

Authors:  Bruno B Andrade; Antonio Reis-Filho; Sebastião Martins Souza-Neto; Imbroinise Raffaele-Netto; Luis M A Camargo; Aldina Barral; Manoel Barral-Netto
Journal:  PLoS Negl Trop Dis       Date:  2010-04-06

3.  Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.

Authors:  Patricia A Reis; Clarissa M Comim; Fernanda Hermani; Bruno Silva; Tatiana Barichello; Aline C Portella; Flavia C A Gomes; Ive M Sab; Valber S Frutuoso; Marcus F Oliveira; Patricia T Bozza; Fernando A Bozza; Felipe Dal-Pizzol; Guy A Zimmerman; João Quevedo; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

4.  Inhibition of Plasmodium falciparum field isolates-mediated endothelial cell apoptosis by Fasudil: therapeutic implications for severe malaria.

Authors:  Estelle S Zang-Edou; Ulrick Bisvigou; Zacharie Taoufiq; Faustin Lékoulou; Jean Bernard Lékana-Douki; Yves Traoré; Dominique Mazier; Fousseyni S Touré-Ndouo
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

5.  Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium.

Authors:  Abhai K Tripathi; Wei Sha; Vladimir Shulaev; Monique F Stins; David J Sullivan
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

6.  Antioxidant therapy: reducing malaria severity?

Authors:  Hans C Ackerman; Steven D Beaudry; Rick M Fairhurst
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

Review 7.  Blood coagulation, inflammation, and malaria.

Authors:  Ivo M B Francischetti; Karl B Seydel; Robson Q Monteiro
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

Review 8.  The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria.

Authors:  Patrice N Mimche; Donatella Taramelli; Livia Vivas
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

9.  Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage.

Authors:  Zacharie Taoufiq; Paco Pino; Nadine N'dilimabaka; Issam Arrouss; Serge Assi; Florent Soubrier; Angelita Rebollo; Dominique Mazier
Journal:  Malar J       Date:  2011-02-28       Impact factor: 2.979

Review 10.  Cerebral malaria: mysteries at the blood-brain barrier.

Authors:  Laurent Rénia; Shanshan Wu Howland; Carla Claser; Anne Charlotte Gruner; Rossarin Suwanarusk; Teck Hui Teo; Bruce Russell; Lisa F P Ng
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.